Abstract

PURPOSE: To describe a framework for screening and treatment of retinopathy of prematurity using telemedicine screening with laser and/or vascular endothelial growth factor inhibitor treatment strategies.DESIGN: Literature review and perspective METHODS: Review of the literature and the author's experience RESULTS: Undetermined CONCLUSIONS: Telemedicine can be deployed on a national basis to provide quaternary level screening for ROP. At-risk patients for treatment could then be directed to receive either laser photocoagulation or vascular endothelial growth factor inhibitor intravitreal injections followed at a later time point by examination under anesthesia, fluorescein angiography, and diode laser photocoagulation as indicated.

View details for PubMedID 29792838